WFG Advisors’s Biogen BIIB Stock Holding History

WFG Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$160K	Buy	590 +342	+138%	+$90.4K	0.04%	422
2017 Q1	$68K	Sell	248 -386	-61%	-$109K	0.02%	588
2016 Q4	$180K	Buy	634 +185	+41%	+$54.8K	0.04%	406
2016 Q3	$141K	Buy	449 +37	+9%	+$11K	0.04%	447
2016 Q2	$100K	Hold	412	–	–	0.03%	493
2016 Q1	$107K	Hold	412	–	–	0.03%	458
2015 Q4	$126K	Hold	412	–	–	0.04%	407
2015 Q3	$120K	Hold	412	–	–	0.04%	415
2015 Q2	$166K	Hold	412	–	–	0.05%	391
2015 Q1	$174K	Hold	412	–	–	0.05%	389
2014 Q4	$140K	Hold	412	–	–	0.03%	542
2014 Q3	$136K	Hold	412	–	–	0.03%	552
2014 Q2	$130K	Hold	412	–	–	0.02%	568
2014 Q1	$126K	Sell	412 -50	-11%	-$15.9K	0.03%	560
2013 Q4	$129K	Buy	462 +50	+12%	+$12.9K	0.02%	649
2013 Q3	$99K	Hold	412	–	–	0.02%	702
2013 Q2	$89K	Buy	+412	New	+$88K	0.01%	698

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WFG Advisors's BIIB Position: Q2 2017 in Review

WFG Advisors increased its Biogen (BIIB) stake by 138% in Q2 2017, buying an estimated $90.4K and bringing the position to 590 shares worth $160K. The position accounts for 0.04% of the portfolio, ranked #422.

WFG Advisors first reported a position in BIIB in Q2 2013 and has held it in 17 quarters since. The position peaked at $180K in Q4 2016. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

WFG Advisors held 590 shares of Biogen worth $160K as of Q2 2017.
WFG Advisors bought 342 Biogen shares in Q2 2017, an estimated $90.4K.
Biogen made up 0.04% of WFG Advisors's portfolio in Q2 2017, its #422 holding.
WFG Advisors first reported a position in Biogen in Q2 2013 and has held it in 17 quarters since.
WFG Advisors's Biogen position peaked at $180K in Q4 2016.
993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.